Yong Li

Dr. Yong Li

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
CJChao Jiang
Chao Jiang
PLPing Luo
Ping Luo
XLXian Li
Xian Li
PLPing Liu
Ping Liu
YLYong Li
Yong Li
JXjie xu
jie xu
Temporomandibular joint osteoarthritis (TMJ OA) is a complex multifactorial disease that can be induced by inflammation and oxidative stress. Curcumin has been reported to have anti-inflammatory and antioxidant properties. Herein, the anti-inflammatory and antioxidant mechanisms of curcumin in TMJ OA were investigated. Curcumin treatment inhibited the expression of the inflammation mediators IL-6, iNOS, and COX-2 and of the matrix-degrading proteinases MMP-1, MMP-3, MMP-9, MMP-13, ADAMTS-4, and ADAMTS-5 and upregulated the mRNA levels of the cartilage anabolic factors COL2A1 and ACAN after IL-1β treatment. Curcumin treatment also decreased oxidative stress injury following IL-1β stimulation. Pathway analysis demonstrated that the ROS/Nrf2/HO-1-SOD2-NQO-1-GCLC signaling axis is a key axis through which curcumin activates the Nrf2/ARE pathway in TMJ inflammatory chondrocytes. Curcumin-induced anti-inflammatory and cartilage protective effects were significantly abrogated by specific Nrf2 siRNA. In vivo results demonstrated that curcumin treatment protected TMJ articular cartilage from progressive degradation. Our experimental results indicate that curcumin inhibits inflammation, oxidative stress, and the matrix degradation of TMJ inflammatory chondrocytes through the Nrf2/ARE signaling pathway, thereby exerting cartilage protective effects. This study provides insight into potential therapeutic approaches for TMJ OA.

Verified
Journal Article
Open access
PDF file
JLJun Li
Jun Li
YBYongjie Bao
Yongjie Bao
SPSisi Peng
Sisi Peng
CJChao Jiang
Chao Jiang
LZLuying Zhu
Luying Zhu
YLYong Li
Yong Li
Exosomes from tumor cells and immune cells regulate the tumor microenvironment through the biomolecules or microRNAs (miRNAs) they carry. This research aims to investigate the role of miRNA in exosomes derived from tumor-associated macrophages (TAMs) in the progression of oral squamous cell carcinoma (OSCC). RT-qPCR and Western blotting assays were used to determine the expression of genes and proteins in OSCC cells. CCK-8, Scratch assay and invasion-related proteins were utilized to detect the malignant progression of tumor cells. High-throughput sequencing predicted differentially expressed miRNAs in exosomes secreted by M0 and M2 macrophages. Compared with exosomes from M0 macrophages, exosomes from M2 macrophages led to enhanced proliferation and invasion of OSCC cells and inhibited their apoptosis. High-throughput sequencing results show that miR-23a-3p is differentially expressed in exosomes from M0 and M2 macrophages. MiRNA target gene database predicts that phosphatase and tensin homolog (PTEN) are target genes of miR-23a-3p. Further studies revealed that transfection of miR-23a-3p mimics inhibited PTEN expression in vivo and in vitro and promoted the malignant progression of OSCC cells, which was reversed by miR-23a-3p inhibitors. MiR-23a-3p in exosomes derived from M2 macrophages promotes malignant progression of OSCC. PTEN is a potential intracellular target of miR-23a-3p. MiR-23a-3p, an M2 macrophage-associated exosome, is a promising target for the future treatment of OSCC.

1 February 2022 in Journal of Proteomics
Verified
Journal Article
Closed access
YHYungang He
Yungang He
PDPingmeng Deng
Pingmeng Deng
YYYing Yan
Ying Yan
LZLuying Zhu
Luying Zhu
HCHongying Chen
Hongying Chen
JLJie Li
Jie Li

28 July 2025 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDPingmeng Deng
Pingmeng Deng
BYBin Yang
Bin Yang
CHChuling Huang
Chuling Huang
YLYuejia Li
Yuejia Li
ZMZiyi Mei
Ziyi Mei
JLJie Li
Jie Li
Mesenchymal stem cell-mediated bone tissue engineering strategies, including human dental pulp stem cells (hDPSCs), represent an effective therapeutic approach for bone defect repair, particularly in maxillofacial bone defects. Growth differentiation factor 15 (GDF15), a multifunctional cytokine, plays a critical role in bone tissue formation and remodeling. This study aims to investigate the effects of GDF15 on the osteogenic differentiation of hDPSCs and elucidate the underlying molecular mechanisms. Our findings demonstrate that GDF15 expression and secretion are upregulated during the osteogenic differentiation of hDPSCs. Both Gdf15 overexpression and recombinant human GDF15 (rhGDF15) treatment significantly enhanced the osteogenic differentiation of hDPSCs, whereas Gdf15 knockdown produced the opposite effect. In vivo experiments demonstrated that hDPSCs treated with rhGDF15 significantly enhanced new bone formation within implants in both nude mouse subcutaneous transplantation and rat calvarial defect models. Proteomic analysis identified significant enrichment of the TGF-β/SMAD signaling pathway. Molecular docking analysis and co-immunoprecipitation demonstrated the direct binding interaction between GDF15 and TGF-βR2. Both in vitro Western blotting and in vivo immunofluorescence assays confirmed pathway activation. Critically, pharmacological inhibition of this pathway partially reversed the rhGDF15-induced enhancement of osteogenic differentiation in hDPSCs. Collectively, our findings demonstrate that GDF15 promotes osteogenic differentiation of hDPSCs through activation of the TGF-β/SMAD signaling pathway, thereby proposing a novel therapeutic strategy for bone repair and regenerative treatment.

11 September 2025 in International Dental Journal
Verified
Journal Article
Open access
LPLi Pan
Li Pan
HWHong-Ning Wang
Hong-Ning Wang
CHChao-Ming Hu
Chao-Ming Hu
JWJun Wang
Jun Wang
WTWen Tong
Wen Tong
YLYong Li
Yong Li
This study aimed to investigate how diabetes mellitus affects palatal wound healing, focusing on inflammatory responses, gene expression dynamics, and fibroblast function. A standardized full-thickness palatal wound model was established in streptozotocin-induced diabetic and non-diabetic rats. Wound healing progression was assessed via gross observation, histological analysis, and immunohistochemistry (CD3, IBA1) at postoperative days (PID) 0, 3, 7, and 14. Wound-edge tissues were collected at PID 0, 3, and 7 for RNA sequencing. The resulting transcriptomic data were analysed using gene set enrichment analysis (GSEA) and weighted gene co-expression network analysis (WGCNA). Primary palatal fibroblasts were isolated from both groups and subjected to in vitro assays assessing proliferation, migration, and ATP production. Diabetic rats exhibited delayed wound closure, defective re-epithelialization, and diminished collagen matrix formation. Immunohistochemistry revealed a biphasic immune response in diabetic wounds, characterized by reduced CD3⁺ and IBA1⁺ cell infiltration at PID 3 and prolonged inflammation at PID 7 and 14. Transcriptomic profiling indicated pre-injury immune activation in diabetic tissues, with elevated inflammatory gene expression at PID 0. Post-injury, diabetes exacerbated tissue repair disruptions, marked by persistent immune activation and suppression of genes involved in extracellular matrix (ECM) organization and metabolic regulation. GSEA revealed marked alterations in oxidative phosphorylation during diabetic wound healing, reflecting mitochondrial dysregulation. WGCNA identified distinct co-expression modules associated with heightened inflammation, impaired ECM remodelling, and perturbed mitochondrial metabolism. Palatal fibroblasts derived from diabetic rats exhibited reduced proliferation, migration, and ATP production, indicating intrinsic functional impairments. Diabetes disrupts the temporal coordination of wound healing, leading to immune dysregulation, metabolic suppression, and fibroblast dysfunction - all of which underpin impaired palatal mucosal repair. These findings provide mechanistic insights and may inform the development of targeted therapies for diabetic wound care.

5 November 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
YYYing Yan
Ying Yan
JLJun Li
Jun Li
YHYungang He
Yungang He
PJPing Ji
Ping Ji
JXjie xu
jie xu
YLYong Li
Yong Li
Inflammation and immunosuppression are important features of tumours, including oral squamous cellular carcinoma (OSCC). Interleukin 37 (IL37), a cytokine known for the ability to suppress inflammation and immunity, shows two seemingly contradictory functions in tumours. This study aims to investigate the mechanism that regulates IL37 and its role in OSCC progression. Herein, IL37, CD86 and CD206 in OSCC specimens were determined. Hypoxia, MCC950 and siRNA‐Gasdermin D (GSDMD) were utilised to investigate the mechanism of IL37 production and release. Animal experiments were established to examine the role of IL37 in OSCC growth in vivo. We found the levels of IL37 are elevated in OSCC tissues compared with normal oral mucosa. In cell experiments, hypoxia was proved to be a vital facilitator in IL37 expression and release. Mechanically, hypoxia promoted IL37 expression through the activation of NACHT–LRR–PYD‐containing protein 3 (NLRP3) inflammasome, and promoted IL37 release via GSDMD. Furthermore, IL37 levels in OSCC specimens are positively correlated with the number of M2 macrophages, but negatively with M1. Further studies revealed IL37 facilitated OSCC progression via promoting macrophage polarization from M1 to M2 and enhancing tumour cell proliferation. Thus, IL37 could be a promising target for OSCC treatment in the future.